Sally Beauty (SBH) Financials

$7.96 -0.06 (-0.70%)

Closing price 05/6/2025 03:59 PM Eastern

Extended Trading

$7.94 -0.03 (-0.36%)

As of 05/6/2025 06:49 PM Eastern

Annual Income Statements for Sally Beauty

This table shows Sally Beauty's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2014	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Net Income / (Loss) Attributable to Common Shareholders	246	235	223	215	258	272	113	240	184	185	153
Consolidated Net Income / (Loss)	246	235	223	215	258	272	113	240	184	185	153
Net Income / (Loss) Continuing Operations	246	235	223	215	258	272	113	240	184	185	153
Total Pre-Tax Income	391	378	354	346	328	362	160	325	244	252	206
Total Operating Income	507	495	498	479	427	458	259	418	338	325	283
Total Gross Profit	1,860	1,898	1,964	1,965	1,944	1,911	1,716	1,953	1,919	1,898	1,890
Total Revenue	3,753	3,834	3,953	3,938	3,933	3,876	3,514	3,875	3,816	3,728	3,717
Operating Revenue	3,753	3,834	3,953	3,938	3,933	3,876	3,514	3,875	3,816	3,728	3,717
Total Cost of Revenue	1,893	1,936	1,989	1,973	1,988	1,966	1,799	1,922	1,896	1,830	1,827
Operating Cost of Revenue	1,893	1,936	1,989	1,973	1,988	1,966	1,799	1,922	1,896	1,830	1,827
Total Operating Expenses	1,353	1,403	1,466	1,486	1,518	1,452	1,457	1,535	1,582	1,573	1,608
Selling, General & Admin Expense	1,274	1,313	1,466	1,464	1,484	1,453	1,443	1,530	1,554	1,556	1,608
Restructuring Charge	-	-	-	23	34	-0.68	14	4.61	28	17	-0.08
Total Other Income / (Expense), net	-116	-117	-144	-133	-98	-96	-99	-94	-94	-73	-76
Interest Expense	116	117	144	133	98	96	99	94	94	73	76
Income Tax Expense	145	143	131	131	70	91	47	85	61	67	53
Basic Earnings per Share	$1.54	$1.50	$1.51	$1.56	$2.09	$2.27	$0.99	$2.13	$1.69	$1.72	$1.48
Weighted Average Basic Shares Outstanding	159.93M	156.35M	147.18M	137.53M	123.19M	119.64M	113.88M	112.65M	108.67M	107.33M	103.94M
Diluted Earnings per Share	$1.51	$1.49	$1.50	$1.56	$2.08	$2.26	$0.99	$2.10	$1.66	$1.69	$1.43
Weighted Average Diluted Shares Outstanding	163.42M	158.23M	148.80M	138.18M	123.83M	120.28M	114.68M	114.21M	110.29M	109.34M	106.93M
Weighted Average Basic & Diluted Shares Outstanding	159.70M	156.70M	147.60M	137.90M	123.50M	116.33M	112.82M	113.05M	107.04M	106.28M	101.88M

This table shows Sally Beauty's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	47	21	50	41	51	43	38	29	38	61
Consolidated Net Income / (Loss)	47	21	50	41	51	43	38	29	38	61
Net Income / (Loss) Continuing Operations	47	21	50	41	51	43	38	29	38	61
Total Pre-Tax Income	63	22	69	55	71	57	52	39	51	83
Total Operating Income	99	39	87	71	90	77	69	60	72	100
Total Gross Profit	490	463	489	468	475	467	467	463	481	477
Total Revenue	961	962	957	919	931	921	931	908	942	938
Operating Revenue	961	962	957	919	931	921	931	908	942	938
Total Cost of Revenue	471	499	468	450	456	455	464	445	461	461
Operating Cost of Revenue	471	499	468	450	456	455	464	445	461	461
Total Operating Expenses	391	424	402	397	385	390	398	403	409	377
Selling, General & Admin Expense	391	398	392	390	384	391	398	403	409	377
Restructuring Charge	0.04	26	10	7.27	0.40	-0.87	-0.09	0.06	0.38	0.00
Total Other Income / (Expense), net	-36	-17	-18	-17	-19	-20	-17	-21	-21	-17
Interest Expense	36	17	18	17	19	20	17	21	21	17
Income Tax Expense	17	0.43	18	14	21	15	13	9.81	13	22
Basic Earnings per Share	$0.44	$0.21	$0.47	$0.38	$0.47	$0.40	$0.36	$0.28	$0.37	$0.60
Weighted Average Basic Shares Outstanding	106.94M	108.67M	107.14M	107.45M	107.56M	107.33M	105.95M	104.28M	103.19M	102.02M
Diluted Earnings per Share	$0.43	$0.21	$0.46	$0.37	$0.46	$0.40	$0.35	$0.27	$0.36	$0.58
Weighted Average Diluted Shares Outstanding	108.53M	110.29M	109.46M	109.71M	109.67M	109.34M	108.72M	107.08M	105.90M	104.97M
Weighted Average Basic & Diluted Shares Outstanding	107.02M	107.04M	107.33M	107.55M	107.77M	106.28M	-	103.51M	102.64M	101.95M

This table details how cash moves in and out of Sally Beauty's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2014	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Net Change in Cash & Equivalents	59	33	-53	-23	14	-5.80	443	-113	-330	52	-15
Net Cash From Operating Activities	316	301	354	343	373	320	427	382	157	249	247
Net Cash From Continuing Operating Activities	316	301	354	343	373	320	427	382	157	249	247
Net Income / (Loss) Continuing Operations	246	235	223	215	258	272	113	240	184	185	153
Consolidated Net Income / (Loss)	246	235	223	215	258	272	113	240	184	185	153
Depreciation Expense	80	89	100	112	109	108	107	102	100	102	110
Amortization Expense	3.76	3.79	3.26	3.26	3.83	3.79	4.12	4.21	3.35	2.69	2.44
Non-Cash Adjustments To Reconcile Net Income	7.82	-2.74	46	47	12	2.59	12	16	51	22	21
Changes in Operating Assets and Liabilities, net	-21	-25	-18	-34	-9.62	-65	191	19	-182	-62	-40
Net Cash From Investing Activities	-82	-113	-175	-90	-95	-96	-124	-76	-102	-100	-109
Net Cash From Continuing Investing Activities	-82	-113	-175	-90	-95	-96	-124	-76	-102	-100	-109
Purchase of Property, Plant & Equipment	-77	-107	-151	-90	-87	-108	-111	-74	-99	-91	-101
Acquisitions	-5.20	-6.47	-26	-	-9.18	-3.42	-13	-2.35	-3.17	-9.03	-7.75
Sale of Property, Plant & Equipment	0.26	0.18	2.53	0.04	0.37	15	0.05	0.24	0.00	0.00	0.00
Net Cash From Financing Activities	-174	-152	-232	-277	-263	-229	140	-420	-374	-101	-154
Net Cash From Continuing Financing Activities	-174	-152	-232	-277	-263	-229	140	-420	-374	-101	-154
Repayment of Debt	-238	-1.81	-951	-1,225	-560	-778	-889	-424	-770	-1,376	-1,635
Repurchase of Common Equity	-333	-228	-209	-347	-167	-47	-61	0.00	-130	-15	-60
Issuance of Debt	356	0.98	912	1,277	462	594	1,088	0.02	520	1,290	1,541
Issuance of Common Equity	-	-	-	-	-	-	-	-	8.11	1.89	1.76
Other Financing Activities, net	41	76	16	17	1.35	2.16	2.79	3.57	-1.18	-1.17	-1.77
Effect of Exchange Rate Changes	-1.02	-2.55	-0.56	-	-	-1.04	-	0.94	-11	-	1.08
Cash Interest Paid	108	113	139	142	90	95	83	89	82	72	87
Cash Income Taxes Paid	139	108	124	115	70	84	50	80	83	64	36

This table details how cash moves in and out of Sally Beauty's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q3 2024	Q4 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-126	-31	29	-37	13	49	-2.00	0.20	11	-2.43
Net Cash From Operating Activities	52	107	55	25	53	117	51	48	111	33
Net Cash From Continuing Operating Activities	52	107	55	25	53	117	51	48	111	33
Net Income / (Loss) Continuing Operations	47	21	50	41	51	43	38	38	48	61
Consolidated Net Income / (Loss)	47	21	50	41	51	43	38	38	48	61
Depreciation Expense	25	27	25	25	25	27	28	29	26	26
Amortization Expense	0.84	0.65	0.65	0.66	0.69	0.70	0.64	0.60	0.57	0.56
Non-Cash Adjustments To Reconcile Net Income	15	27	7.32	4.03	-11	21	5.12	6.50	3.78	-20
Changes in Operating Assets and Liabilities, net	-35	32	-29	-46	-13	25	-21	-25	32	-34
Net Cash From Investing Activities	-23	-35	-25	-17	-22	-36	-31	-19	-45	23
Net Cash From Continuing Investing Activities	-23	-35	-25	-17	-22	-36	-31	-19	-45	23
Purchase of Property, Plant & Equipment	-23	-32	-25	-17	-22	-27	-31	-19	-37	-20
Acquisitions	-0.35	-2.50	0.00	-	-	-9.03	-0.22	-	-7.53	-0.37
Sale of Property, Plant & Equipment	-	-	-	-	-	-	0.00	-	-	44
Net Cash From Financing Activities	-147	-100	-5.99	-43	-19	-33	-23	-29	-56	-58
Net Cash From Continuing Financing Activities	-147	-100	-5.99	-43	-19	-33	-23	-29	-56	-58
Repayment of Debt	-431	-337	-234	-669	-235	-238	-68	-308	-242	-155
Repurchase of Common Equity	-	-	0.00	-	-	-15	-20	-10	-9.89	-9.95
Issuance of Debt	283	237	229	624	216	221	67	289	196	112
Issuance of Common Equity	0.25	0.06	0.06	1.66	0.08	0.08	0.22	0.04	0.11	0.08
Other Financing Activities, net	-0.03	-0.00	-1.13	-0.02	-	-0.03	-1.74	0.00	-0.01	-5.26
Other Net Changes in Cash	-	-	4.56	-	-	0.67	-	-	-	-1.35
Cash Interest Paid	38	6.41	27	8.43	28	8.49	27	8.25	30	7.65
Cash Income Taxes Paid	17	8.75	3.08	29	20	12	3.50	2.47	1.51	19

This table presents Sally Beauty's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2014	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Total Assets	2,004	2,094	2,132	2,099	2,097	2,098	2,895	2,847	2,577	2,725	2,793
Total Current Assets	1,104	1,187	1,173	1,142	1,155	1,164	1,433	1,384	1,132	1,228	1,305
Cash & Equivalents	107	140	87	64	77	71	514	401	71	123	108
Accounts Receivable	99	91	84	92	90	105	56	67	72	76	92
Inventories, net	828	885	907	931	944	953	815	871	936	975	1,037
Other Current Assets	39	37	55	55	43	35	48	45	53	54	69
Plant, Property, & Equipment, net	238	271	320	314	308	320	315	307	298	298	270
Total Noncurrent Assets	662	636	640	643	634	615	1,147	1,156	1,147	1,199	1,218
Goodwill	536	524	533	538	536	531	540	541	526	533	538
Intangible Assets	115	99	93	80	73	62	58	56	50	55	60
Other Noncurrent Operating Assets	11	13	14	25	25	22	549	559	570	611	619
Total Liabilities & Shareholders' Equity	2,004	2,094	2,132	2,099	2,097	2,098	2,895	2,847	2,577	2,725	2,793
Total Liabilities	2,351	2,392	2,408	2,463	2,366	2,159	2,880	2,566	2,283	2,217	2,164
Total Current Liabilities	464	492	489	573	491	456	563	665	668	579	593
Short-Term Debt	0.97	0.76	0.72	96	5.50	0.00	0.18	0.19	69	4.17	4.13
Accounts Payable	259	276	271	308	303	279	236	292	276	259	269
Accrued Expenses	199	209	215	167	180	169	171	206	161	163	163
Current Deferred & Payable Income Tax Liabilities	4.33	6.31	1.99	2.23	2.14	8.34	2.92	11	4.74	2.36	20
Other Current Liabilities	-	-	-	-	-	0.00	153	156	158	150	136
Total Noncurrent Liabilities	1,888	1,900	1,920	1,890	1,875	1,703	2,316	1,902	1,615	1,637	1,572
Long-Term Debt	1,785	1,787	1,783	1,772	1,769	1,595	1,797	1,383	1,083	1,066	978
Capital Lease Obligations	-	-	-	-	-	-	-	404	425	455	480
Noncurrent Deferred & Payable Income Tax Liabilities	75	86	115	98	76	80	92	86	85	93	92
Other Noncurrent Operating Liabilities	28	28	22	20	30	28	427	29	22	23	22
Total Equity & Noncontrolling Interests	-347	-298	-276	-364	-269	-60	15	281	294	509	629
Total Preferred & Common Equity	-347	-298	-276	-364	-269	-60	15	281	294	509	629
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	-347	-298	-276	-364	-269	-60	15	281	294	509	629
Common Stock	1.55	1.52	1.45	1.30	1.20	1.17	3.04	18	5.31	6.74	1.02
Retained Earnings	-320	-219	-178	-283	-180	56	117	357	440	625	741
Accumulated Other Comprehensive Income / (Loss)	-29	-78	-100	-82	-90	-117	-105	-95	-152	-123	-113

This table presents Sally Beauty's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q2 2024	Q3 2024	Q1 2025
Period end date	6/30/2022	12/31/2022	3/31/2023	6/30/2023	3/31/2024	6/30/2024	12/31/2024
Total Assets	2,686	2,669	2,675	2,675	2,747	2,721	2,711
Total Current Assets	1,243	1,219	1,209	1,199	1,280	1,263	1,247
Cash & Equivalents	101	99	62	74	97	97	106
Accounts Receivable	67	75	76	78	88	91	85
Inventories, net	1,015	987	1,024	996	1,040	1,022	1,006
Other Current Assets	60	58	48	51	56	51	51
Plant, Property, & Equipment, net	290	289	283	281	273	268	262
Total Noncurrent Assets	1,153	1,161	1,183	1,195	1,193	1,191	1,202
Goodwill	533	533	534	535	534	534	531
Intangible Assets	50	51	51	50	54	53	58
Other Noncurrent Operating Assets	569	577	598	610	604	604	613
Total Liabilities & Shareholders' Equity	2,686	2,669	2,675	2,675	2,747	2,721	2,711
Total Liabilities	2,390	2,295	2,249	2,188	2,196	2,144	2,054
Total Current Liabilities	775	677	631	566	644	595	549
Short-Term Debt	167	65	38	20	66	49	4.08
Accounts Payable	279	296	265	244	290	235	221
Accrued Expenses	166	143	168	140	150	161	149
Current Deferred & Payable Income Tax Liabilities	2.99	17	4.95	6.35	0.37	13	22
Other Current Liabilities	159	156	154	155	138	137	152
Total Noncurrent Liabilities	1,615	1,618	1,619	1,622	1,552	1,549	1,506
Long-Term Debt	1,084	1,082	1,065	1,065	978	979	938
Capital Lease Obligations	421	427	445	451	458	457	457
Noncurrent Deferred & Payable Income Tax Liabilities	93	86	86	84	94	91	89
Other Noncurrent Operating Liabilities	17	23	22	22	22	21	22
Total Equity & Noncontrolling Interests	296	373	426	488	551	578	656
Total Preferred & Common Equity	296	373	426	488	551	578	656
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	296	373	426	488	551	578	656
Common Stock	3.41	9.40	15	18	1.04	1.03	1.02
Retained Earnings	419	491	531	582	667	698	793
Accumulated Other Comprehensive Income / (Loss)	-126	-127	-120	-113	-117	-122	-137

This table displays calculated financial ratios and metrics derived from Sally Beauty's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	9/30/2014	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3.62%	2.15%	3.08%	-0.36%	-0.15%	-1.43%	-9.34%	10.26%	-1.53%	-2.29%	-0.30%
EBITDA Growth	-0.96%	-0.32%	2.16%	-1.17%	-9.25%	5.69%	-35.14%	41.98%	-15.99%	-2.45%	-8.19%
EBIT Growth	-2.57%	-2.30%	0.60%	-3.95%	-10.87%	7.47%	-43.56%	61.71%	-19.31%	-3.74%	-13.01%
NOPAT Growth	-3.06%	-3.62%	1.98%	-5.10%	12.57%	2.59%	-46.73%	68.62%	-17.80%	-6.24%	-11.69%
Net Income Growth	-5.80%	-4.43%	-5.17%	-3.53%	19.98%	5.26%	-58.31%	111.80%	-23.47%	0.57%	-16.89%
EPS Growth	2.03%	-1.32%	0.67%	4.00%	33.33%	8.65%	-56.19%	112.12%	-20.95%	1.81%	-15.38%
Operating Cash Flow Growth	1.78%	-4.81%	17.73%	-3.06%	8.56%	-14.02%	33.23%	-10.55%	-59.02%	59.30%	-1.12%
Free Cash Flow Firm Growth	30.21%	-11.22%	-16.54%	14.92%	24.73%	-10.85%	12.26%	-117.09%	303.71%	4.78%	9.20%
Invested Capital Growth	-0.58%	1.30%	5.30%	1.36%	-0.84%	2.40%	-11.24%	28.37%	7.97%	6.18%	3.76%
Revenue Q/Q Growth	1.02%	0.52%	0.31%	-0.05%	-0.21%	0.00%	-0.23%	0.84%	-0.72%	-1.09%	0.00%
EBITDA Q/Q Growth	-0.05%	-0.44%	-1.10%	0.38%	-1.73%	2.28%	0.70%	-1.97%	-13.67%	9.64%	0.00%
EBIT Q/Q Growth	-0.39%	-1.37%	-1.66%	0.20%	-1.98%	2.91%	1.40%	-1.99%	-17.58%	13.13%	0.00%
NOPAT Q/Q Growth	-0.59%	-1.93%	-1.60%	-0.46%	-0.20%	3.90%	4.08%	-2.70%	-15.70%	9.87%	0.00%
Net Income Q/Q Growth	-1.23%	-2.31%	-1.57%	-7.29%	8.16%	5.36%	1.05%	-0.84%	-20.32%	13.00%	0.00%
EPS Q/Q Growth	0.67%	-1.97%	-0.66%	-4.29%	9.47%	6.10%	4.21%	-1.41%	-19.02%	12.67%	0.00%
Operating Cash Flow Q/Q Growth	2.99%	-8.69%	3.33%	4.61%	-7.38%	8.78%	9.19%	3.14%	-26.65%	3.86%	-2.32%
Free Cash Flow Firm Q/Q Growth	30.02%	-16.06%	-16.36%	12.05%	-3.79%	9.07%	6.93%	-118.83%	152.55%	-5.57%	0.00%
Invested Capital Q/Q Growth	-5.68%	-2.23%	0.82%	-1.36%	-0.47%	-1.32%	-2.62%	24.82%	-3.60%	-1.97%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.56%	49.50%	49.69%	49.89%	49.44%	49.29%	48.82%	50.41%	50.30%	50.92%	50.86%
EBITDA Margin	15.73%	15.35%	15.21%	15.09%	13.71%	14.70%	10.52%	13.54%	11.56%	11.54%	10.62%
Operating Margin	13.51%	12.92%	12.61%	12.15%	10.85%	11.83%	7.36%	10.80%	8.85%	8.72%	7.61%
EBIT Margin	13.51%	12.92%	12.61%	12.15%	10.85%	11.83%	7.36%	10.80%	8.85%	8.72%	7.61%
Profit (Net Income) Margin	6.55%	6.13%	5.64%	5.46%	6.56%	7.01%	3.22%	6.19%	4.81%	4.95%	4.13%
Tax Burden Percent	62.97%	62.11%	62.97%	62.22%	78.57%	75.00%	70.79%	73.82%	75.20%	73.24%	74.36%
Interest Burden Percent	77.06%	76.41%	71.05%	72.23%	76.99%	78.99%	61.82%	77.65%	72.30%	77.55%	72.98%
Effective Tax Rate	37.03%	37.89%	37.03%	37.79%	21.43%	25.00%	29.21%	26.18%	24.80%	26.76%	25.64%
Return on Invested Capital (ROIC)	23.89%	22.94%	22.65%	20.81%	23.37%	23.79%	13.27%	20.84%	14.65%	12.83%	10.80%
ROIC Less NNEP Spread (ROIC-NNEP)	19.48%	18.58%	17.22%	16.09%	18.96%	19.30%	8.28%	15.66%	9.78%	9.16%	6.68%
Return on Net Nonoperating Assets (RNNOA)	-99.52%	-95.85%	-100.33%	-88.04%	-105.00%	-188.97%	-517.93%	141.13%	49.26%	33.18%	16.18%
Return on Equity (ROE)	-75.63%	-72.91%	-77.68%	-67.23%	-81.64%	-165.18%	-504.66%	161.97%	63.91%	46.01%	26.98%
Cash Return on Invested Capital (CROIC)	24.47%	21.65%	17.49%	19.46%	24.21%	21.42%	25.17%	-4.01%	6.98%	6.83%	7.11%
Operating Return on Assets (OROA)	25.64%	24.17%	23.58%	22.62%	20.33%	21.85%	10.36%	14.57%	12.45%	12.26%	10.25%
Return on Assets (ROA)	12.44%	11.47%	10.55%	10.17%	12.30%	12.95%	4.54%	8.35%	6.77%	6.96%	5.56%
Return on Common Equity (ROCE)	-75.63%	-72.91%	-77.68%	-67.23%	-81.64%	-165.18%	-504.66%	161.97%	63.91%	46.01%	26.98%
Return on Equity Simple (ROE_SIMPLE)	-70.88%	-78.94%	-80.73%	-59.15%	-96.09%	-450.28%	733.31%	85.44%	62.51%	36.29%	24.41%
Net Operating Profit after Tax (NOPAT)	319	308	314	298	335	344	183	309	254	238	210
NOPAT Margin	8.50%	8.02%	7.94%	7.56%	8.52%	8.87%	5.21%	7.97%	6.65%	6.39%	5.66%
Net Nonoperating Expense Percent (NNEP)	4.41%	4.36%	5.43%	4.72%	4.41%	4.49%	4.99%	5.17%	4.86%	3.68%	4.12%
Cost of Revenue to Revenue	50.44%	50.50%	50.31%	50.11%	50.56%	50.71%	51.18%	49.59%	49.70%	49.08%	49.14%
SG&A Expenses to Revenue	33.93%	34.25%	37.08%	37.16%	37.74%	37.48%	41.06%	39.49%	40.73%	41.74%	43.25%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	36.05%	36.58%	37.08%	37.74%	38.60%	37.46%	41.45%	39.61%	41.45%	42.20%	43.25%
Earnings before Interest and Taxes (EBIT)	507	495	498	479	427	458	259	418	338	325	283
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	590	589	601	594	539	570	370	525	441	430	395
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	0.00	0.00	0.00	63.50	6.78	4.59	1.78	2.22
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	45.96
Price to Revenue (P/Rev)	1.13	0.97	0.95	0.65	0.56	0.46	0.28	0.49	0.35	0.24	0.37
Price to Earnings (P/E)	17.26	15.89	16.87	11.96	8.56	6.61	8.66	7.94	7.35	4.89	9.08
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.79%	6.29%	5.93%	8.36%	11.68%	15.13%	11.55%	12.59%	13.61%	20.44%	11.01%
Enterprise Value to Invested Capital (EV/IC)	4.45	3.99	3.84	3.04	2.73	2.27	1.74	1.97	1.59	1.21	1.39
Enterprise Value to Revenue (EV/Rev)	1.58	1.40	1.38	1.11	0.99	0.86	0.64	0.85	0.75	0.62	0.74
Enterprise Value to EBITDA (EV/EBITDA)	10.04	9.15	9.08	7.37	7.24	5.82	6.12	6.27	6.47	5.36	6.96
Enterprise Value to EBIT (EV/EBIT)	11.69	10.87	10.95	9.14	9.16	7.24	8.75	7.86	8.45	7.09	9.72
Enterprise Value to NOPAT (EV/NOPAT)	18.56	17.50	17.40	14.70	11.65	9.65	12.36	10.65	11.24	9.68	13.07
Enterprise Value to Operating Cash Flow (EV/OCF)	18.76	17.90	15.41	12.75	10.48	10.36	5.30	8.62	18.24	9.25	11.14
Enterprise Value to Free Cash Flow (EV/FCFF)	18.12	18.54	22.53	15.72	11.25	10.72	6.51	0.00	23.59	18.18	19.84
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-5.15	-6.00	-6.46	-5.14	-6.61	-26.43	116.37	6.36	5.37	3.00	2.33
Long-Term Debt to Equity	-5.14	-6.00	-6.46	-4.87	-6.59	-26.43	116.36	6.36	5.13	2.99	2.32
Financial Leverage	-5.11	-5.16	-5.83	-5.47	-5.54	-9.79	-62.52	9.01	5.03	3.62	2.42
Leverage Ratio	-6.08	-6.36	-7.36	-6.61	-6.64	-12.76	-111.27	19.39	9.44	6.61	4.85
Compound Leverage Factor	-4.68	-4.86	-5.23	-4.78	-5.11	-10.08	-68.79	15.06	6.83	5.12	3.54
Debt to Total Capital	124.12%	119.99%	118.32%	124.17%	117.84%	103.93%	99.15%	86.42%	84.30%	74.99%	69.93%
Short-Term Debt to Total Capital	0.07%	0.05%	0.05%	6.39%	0.37%	0.00%	0.01%	0.01%	3.67%	0.21%	0.20%
Long-Term Debt to Total Capital	124.05%	119.94%	118.27%	117.78%	117.47%	103.93%	99.14%	86.41%	80.63%	74.78%	69.74%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	-24.12%	-19.99%	-18.32%	-24.17%	-17.84%	-3.93%	0.85%	13.58%	15.70%	25.01%	30.07%
Debt to EBITDA	3.03	3.04	2.97	3.14	3.29	2.80	4.86	3.40	3.58	3.55	3.70
Net Debt to EBITDA	2.84	2.80	2.82	3.04	3.15	2.67	3.47	2.64	3.42	3.26	3.43
Long-Term Debt to EBITDA	3.02	3.04	2.97	2.98	3.28	2.80	4.86	3.40	3.42	3.54	3.69
Debt to NOPAT	5.59	5.81	5.69	6.27	5.29	4.64	9.81	5.78	6.21	6.41	6.95
Net Debt to NOPAT	5.26	5.36	5.41	6.06	5.06	4.43	7.00	4.49	5.93	5.89	6.44
Long-Term Debt to NOPAT	5.59	5.81	5.68	5.95	5.28	4.64	9.81	5.78	5.94	6.39	6.93
Altman Z-Score	3.95	3.80	3.83	3.39	3.37	3.51	2.13	2.77	2.72	2.61	2.73
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.38	2.41	2.40	1.99	2.35	2.55	2.54	2.08	1.70	2.12	2.20
Quick Ratio	0.44	0.47	0.35	0.27	0.34	0.39	1.01	0.70	0.21	0.34	0.34
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	327	290	242	278	347	310	348	-59	121	127	138
Operating Cash Flow to CapEx	412.73%	282.83%	238.16%	383.02%	432.63%	346.61%	385.26%	518.35%	157.68%	274.75%	243.69%
Free Cash Flow to Firm to Interest Expense	2.81	2.48	1.68	2.10	3.54	3.21	3.52	-0.64	1.29	1.74	1.81
Operating Cash Flow to Interest Expense	2.72	2.57	2.46	2.58	3.80	3.33	4.32	4.08	1.67	3.42	3.23
Operating Cash Flow Less CapEx to Interest Expense	2.06	1.66	1.42	1.91	2.92	2.37	3.20	3.30	0.61	2.17	1.90
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.90	1.87	1.87	1.86	1.87	1.85	1.41	1.35	1.41	1.41	1.35
Accounts Receivable Turnover	38.55	40.45	45.15	44.70	43.04	39.75	43.67	63.00	54.96	50.33	44.23
Inventory Turnover	2.31	2.26	2.22	2.15	2.12	2.07	2.04	2.28	2.10	1.91	1.82
Fixed Asset Turnover	16.05	15.07	13.39	12.44	12.64	12.35	11.07	12.45	12.61	12.52	13.10
Accounts Payable Turnover	7.11	7.23	7.27	6.82	6.51	6.76	6.99	7.28	6.69	6.85	6.92
Days Sales Outstanding (DSO)	9.47	9.02	8.08	8.17	8.48	9.18	8.36	5.79	6.64	7.25	8.25
Days Inventory Outstanding (DIO)	157.77	161.50	164.50	169.99	172.13	176.13	179.32	160.11	173.97	190.64	201.00
Days Payable Outstanding (DPO)	51.37	50.46	50.22	53.56	56.09	54.02	52.25	50.14	54.60	53.32	52.78
Cash Conversion Cycle (CCC)	115.87	120.07	122.36	124.60	124.53	131.29	135.43	115.76	126.01	144.58	156.47
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,332	1,350	1,421	1,441	1,428	1,463	1,298	1,667	1,800	1,911	1,983
Invested Capital Turnover	2.81	2.86	2.85	2.75	2.74	2.68	2.55	2.61	2.20	2.01	1.91
Increase / (Decrease) in Invested Capital	-7.75	17	71	19	-12	34	-164	368	133	111	72
Enterprise Value (EV)	5,926	5,383	5,458	4,376	3,906	3,318	2,264	3,291	2,854	2,305	2,747
Market Capitalization	4,247	3,735	3,761	2,572	2,209	1,795	981	1,905	1,348	903	1,393
Book Value per Share	($2.24)	($1.89)	($1.89)	($2.77)	($2.24)	($0.50)	$0.14	$2.48	$2.74	$4.72	$6.12
Tangible Book Value per Share	($6.43)	($5.86)	($6.16)	($7.47)	($7.30)	($5.42)	($5.17)	($2.80)	($2.64)	($0.74)	$0.30
Total Capital	1,439	1,490	1,508	1,504	1,506	1,534	1,813	2,068	1,870	2,034	2,091
Total Debt	1,786	1,788	1,784	1,868	1,774	1,595	1,797	1,787	1,576	1,525	1,462
Total Long-Term Debt	1,785	1,787	1,783	1,772	1,769	1,595	1,797	1,787	1,508	1,521	1,458
Net Debt	1,679	1,648	1,697	1,804	1,697	1,523	1,283	1,386	1,506	1,402	1,354
Capital Expenditures (CapEx)	77	106	149	90	86	92	111	74	99	91	101
Debt-free, Cash-free Net Working Capital (DFCFNWC)	535	556	598	602	592	636	356	318	463	530	609
Debt-free Net Working Capital (DFNWC)	642	696	685	666	669	707	870	719	533	653	717
Net Working Capital (NWC)	641	695	684	569	664	707	870	719	464	649	713
Net Nonoperating Expense (NNE)	73	73	91	83	77	72	70	69	70	53	57
Net Nonoperating Obligations (NNO)	1,679	1,648	1,697	1,804	1,697	1,523	1,283	1,386	1,506	1,402	1,354
Total Depreciation and Amortization (D&A)	83	93	103	116	113	111	111	106	103	105	112
Debt-free, Cash-free Net Working Capital to Revenue	14.25%	14.50%	15.14%	15.28%	15.06%	16.41%	10.12%	8.20%	12.12%	14.21%	16.38%
Debt-free Net Working Capital to Revenue	17.09%	18.16%	17.33%	16.90%	17.02%	18.25%	24.75%	18.55%	13.97%	17.51%	19.28%
Net Working Capital to Revenue	17.07%	18.14%	17.31%	14.46%	16.88%	18.25%	24.75%	18.55%	12.17%	17.40%	19.17%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.54	$1.50	$1.51	$1.56	$2.09	$2.27	$0.99	$2.13	$1.69	$1.72	$1.48
Adjusted Weighted Average Basic Shares Outstanding	159.93M	156.35M	147.18M	137.53M	123.19M	119.64M	113.88M	112.65M	108.67M	107.33M	103.94M
Adjusted Diluted Earnings per Share	$1.51	$1.49	$1.50	$1.56	$2.08	$2.26	$0.99	$2.10	$1.66	$1.69	$1.43
Adjusted Weighted Average Diluted Shares Outstanding	163.42M	158.23M	148.80M	138.18M	123.83M	120.28M	114.68M	114.21M	110.29M	109.34M	106.93M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	155.20M	151.86M	144.11M	128.43M	120.14M	116.33M	112.82M	113.05M	107.04M	106.28M	101.88M
Normalized Net Operating Profit after Tax (NOPAT)	319	308	314	312	362	343	193	312	275	251	210
Normalized NOPAT Margin	8.50%	8.02%	7.94%	7.92%	9.19%	8.86%	5.50%	8.06%	7.20%	6.72%	5.65%
Pre Tax Income Margin	10.41%	9.87%	8.96%	8.78%	8.35%	9.34%	4.55%	8.39%	6.40%	6.76%	5.55%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.36	4.24	3.45	3.60	4.35	4.76	2.62	4.47	3.61	4.45	3.70
NOPAT to Interest Expense	2.74	2.63	2.18	2.24	3.41	3.57	1.85	3.30	2.71	3.26	2.75
EBIT Less CapEx to Interest Expense	3.70	3.33	2.42	2.93	3.47	3.80	1.50	3.69	2.55	3.21	2.38
NOPAT Less CapEx to Interest Expense	2.09	1.72	1.14	1.57	2.54	2.61	0.73	2.52	1.65	2.02	1.43
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	135.49%	96.80%	93.78%	161.28%	64.60%	17.46%	54.18%	0.00%	71.00%	8.21%	39.37%

This table displays calculated financial ratios and metrics derived from Sally Beauty's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Period end date	6/30/2022	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.96%	-2.81%	-2.37%	0.80%	-3.17%	-4.27%	-2.69%	-1.13%	1.22%	0.71%
EBITDA Growth	-18.62%	-51.25%	-18.54%	-12.84%	-6.96%	56.96%	-13.06%	-38.67%	-13.21%	29.26%
EBIT Growth	-22.14%	-64.75%	-23.22%	-17.41%	-9.15%	96.21%	-20.17%	-16.57%	-20.37%	45.13%
NOPAT Growth	-21.77%	-53.85%	-24.34%	-12.30%	-12.29%	49.01%	-19.31%	-16.33%	-17.26%	44.19%
Net Income Growth	-38.89%	-68.69%	-26.88%	-12.71%	9.14%	99.54%	-23.73%	-28.43%	-25.77%	58.93%
EPS Growth	-34.85%	-65.00%	-23.33%	-11.90%	6.98%	90.48%	-23.91%	-27.03%	-21.74%	65.71%
Operating Cash Flow Growth	-39.66%	-34.64%	1,066.60%	748.11%	2.16%	8.64%	-7.15%	0.00%	-9.84%	-34.42%
Free Cash Flow Firm Growth	-601.28%	66.86%	-635.61%	94.17%	96.01%	42.83%	552.08%	104.06%	300.12%	-198.74%
Invested Capital Growth	39.80%	7.97%	35.44%	4.37%	4.41%	6.18%	0.00%	2.28%	0.84%	0.00%
Revenue Q/Q Growth	5.49%	0.10%	-0.56%	-4.01%	1.34%	-1.04%	1.08%	0.00%	3.74%	0.00%
EBITDA Q/Q Growth	12.10%	-46.84%	69.43%	-13.68%	19.67%	-10.32%	-6.16%	0.00%	69.35%	0.00%
EBIT Q/Q Growth	14.74%	-60.49%	120.91%	-17.53%	26.21%	-14.67%	-10.12%	0.00%	20.47%	0.00%
NOPAT Q/Q Growth	20.17%	-47.41%	65.19%	-16.00%	20.19%	-10.65%	-10.55%	0.00%	18.85%	0.00%
Net Income Q/Q Growth	-0.51%	-54.17%	135.88%	-18.83%	24.38%	-16.21%	-9.84%	0.00%	29.00%	0.00%
EPS Q/Q Growth	2.38%	-51.16%	119.05%	-19.57%	24.32%	-13.04%	-12.50%	0.00%	33.33%	0.00%
Operating Cash Flow Q/Q Growth	1,685.71%	106.29%	-48.77%	-55.06%	115.10%	119.38%	-56.22%	0.00%	0.00%	-69.77%
Free Cash Flow Firm Q/Q Growth	-0.03%	79.39%	-344.92%	93.65%	31.43%	-194.89%	3,618.45%	0.00%	3,280.53%	0.00%
Invested Capital Q/Q Growth	1.86%	-3.60%	2.73%	3.46%	1.90%	-1.97%	-100.00%	0.00%	0.47%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	50.99%	48.16%	51.05%	50.98%	50.99%	50.64%	50.16%	50.98%	51.03%	50.84%
EBITDA Margin	12.99%	6.90%	11.76%	10.57%	12.49%	11.31%	10.50%	6.56%	10.71%	13.48%
Operating Margin	10.32%	4.07%	9.05%	7.77%	9.68%	8.35%	7.42%	6.56%	7.62%	10.70%
EBIT Margin	10.32%	4.07%	9.05%	7.77%	9.68%	8.35%	7.42%	6.56%	7.62%	10.70%
Profit (Net Income) Margin	4.84%	2.22%	5.26%	4.45%	5.46%	4.62%	4.12%	3.22%	4.00%	6.51%
Tax Burden Percent	73.65%	98.04%	73.31%	74.67%	71.11%	74.45%	74.10%	74.89%	73.88%	73.62%
Interest Burden Percent	63.73%	55.53%	79.30%	76.63%	79.30%	74.36%	74.95%	65.55%	71.15%	82.61%
Effective Tax Rate	26.35%	1.96%	26.69%	25.33%	28.89%	25.55%	25.90%	25.11%	26.12%	26.38%
Return on Invested Capital (ROIC)	18.24%	8.79%	15.65%	11.78%	13.60%	12.49%	0.00%	0.00%	0.00%	30.08%
ROIC Less NNEP Spread (ROIC-NNEP)	16.27%	7.61%	14.63%	10.96%	12.72%	11.48%	0.00%	0.00%	0.00%	28.09%
Return on Net Nonoperating Assets (RNNOA)	84.27%	38.31%	57.21%	47.86%	49.24%	41.60%	0.00%	0.00%	0.00%	55.34%
Return on Equity (ROE)	102.51%	47.10%	72.87%	59.64%	62.84%	54.09%	0.00%	0.00%	0.00%	85.42%
Cash Return on Invested Capital (CROIC)	-14.38%	6.98%	-15.58%	7.81%	7.04%	6.83%	0.00%	0.00%	0.00%	-176.12%
Operating Return on Assets (OROA)	14.52%	5.73%	12.42%	10.90%	13.61%	11.74%	0.00%	0.00%	0.00%	14.69%
Return on Assets (ROA)	6.81%	3.12%	7.22%	6.24%	7.68%	6.50%	0.00%	0.00%	0.00%	8.94%
Return on Common Equity (ROCE)	102.51%	47.10%	72.87%	59.64%	62.84%	54.09%	0.00%	0.00%	0.00%	85.42%
Return on Equity Simple (ROE_SIMPLE)	77.86%	0.00%	44.21%	37.36%	33.50%	0.00%	0.00%	0.00%	0.00%	26.81%
Net Operating Profit after Tax (NOPAT)	73	38	63	53	64	57	51	45	53	74
NOPAT Margin	7.60%	3.99%	6.63%	5.80%	6.88%	6.21%	5.50%	4.91%	5.63%	7.87%
Net Nonoperating Expense Percent (NNEP)	1.97%	1.18%	1.03%	0.82%	0.87%	1.01%	0.00%	1.06%	1.07%	1.99%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	3.59%
Cost of Revenue to Revenue	49.01%	51.84%	48.95%	49.02%	49.01%	49.36%	49.84%	49.02%	48.97%	49.16%
SG&A Expenses to Revenue	40.66%	41.34%	40.92%	42.41%	41.27%	42.39%	42.75%	44.41%	43.37%	40.15%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	40.67%	44.08%	42.00%	43.21%	41.31%	42.29%	42.74%	44.42%	43.41%	40.15%
Earnings before Interest and Taxes (EBIT)	99	39	87	71	90	77	69	60	72	100
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	125	66	113	97	116	104	98	60	101	126
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.31	4.59	3.59	3.93	2.72	1.78	0.00	0.00	1.92	1.62
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.82
Price to Revenue (P/Rev)	0.33	0.35	0.35	0.44	0.35	0.24	0.39	0.00	0.00	0.29
Price to Earnings (P/E)	5.54	7.35	8.12	10.51	8.13	4.89	8.29	0.00	0.00	6.05
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	18.06%	13.61%	12.32%	9.51%	12.30%	20.44%	12.06%	0.00%	0.00%	16.53%
Enterprise Value to Invested Capital (EV/IC)	1.52	1.59	1.52	1.65	1.43	1.21	0.00	0.00	1.27	1.21
Enterprise Value to Revenue (EV/Rev)	0.74	0.75	0.74	0.83	0.74	0.62	0.00	0.00	0.00	0.63
Enterprise Value to EBITDA (EV/EBITDA)	5.57	6.47	6.78	7.88	7.11	5.36	0.00	0.00	0.00	5.57
Enterprise Value to EBIT (EV/EBIT)	6.95	8.45	9.04	10.66	9.71	7.09	0.00	0.00	0.00	7.51
Enterprise Value to NOPAT (EV/NOPAT)	9.45	11.24	12.06	13.96	12.88	9.68	0.00	0.00	0.00	10.13
Enterprise Value to Operating Cash Flow (EV/OCF)	13.34	18.24	12.97	13.22	11.62	9.25	0.00	0.00	9.90	10.30
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	23.59	0.00	21.60	20.78	18.18	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	5.65	5.37	4.22	3.64	3.15	3.00	0.00	2.73	2.57	2.13
Long-Term Debt to Equity	5.09	5.13	4.04	3.55	3.11	2.99	0.00	2.61	2.49	2.12
Financial Leverage	5.18	5.03	3.91	4.37	3.87	3.62	0.00	2.96	2.67	1.97
Leverage Ratio	10.55	9.44	8.44	7.77	6.84	6.61	0.00	5.55	5.07	4.13
Compound Leverage Factor	6.72	5.24	6.70	5.95	5.43	4.91	0.00	3.64	3.60	3.41
Debt to Total Capital	84.97%	84.30%	80.84%	78.43%	75.90%	74.99%	0.00%	73.17%	72.00%	68.06%
Short-Term Debt to Total Capital	8.49%	3.67%	3.35%	1.93%	1.00%	0.21%	0.00%	3.22%	2.38%	0.20%
Long-Term Debt to Total Capital	76.47%	80.63%	77.49%	76.50%	74.90%	74.78%	0.00%	69.95%	69.61%	67.86%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	15.03%	15.70%	19.17%	21.57%	24.10%	25.01%	0.00%	26.83%	28.00%	31.94%
Debt to EBITDA	3.27	3.58	3.79	3.86	3.91	3.55	0.00	0.00	0.00	3.30
Net Debt to EBITDA	3.08	3.42	3.55	3.71	3.73	3.26	0.00	0.00	0.00	3.05
Long-Term Debt to EBITDA	2.95	3.42	3.63	3.77	3.86	3.54	0.00	0.00	0.00	3.29
Debt to NOPAT	5.55	6.21	6.75	6.84	7.09	6.41	0.00	0.00	0.00	6.01
Net Debt to NOPAT	5.22	5.93	6.32	6.57	6.74	5.89	0.00	0.00	0.00	5.56
Long-Term Debt to NOPAT	5.00	5.94	6.47	6.67	6.99	6.39	0.00	0.00	0.00	5.99
Altman Z-Score	2.30	2.34	2.38	2.49	2.47	2.31	0.00	0.00	0.00	2.53
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.60	1.70	1.80	1.92	2.12	2.12	0.00	1.99	2.12	2.27
Quick Ratio	0.22	0.21	0.26	0.22	0.27	0.34	0.00	0.29	0.32	0.35
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-458	-94	-420	-27	-18	-54	1,900	1.08	37	-1,876
Operating Cash Flow to CapEx	224.86%	335.06%	219.74%	143.80%	245.77%	432.49%	167.00%	0.00%	250.12%	0.00%
Free Cash Flow to Firm to Interest Expense	-12.74	-5.42	-23.45	-1.60	-0.98	-2.74	109.74	0.05	1.77	-107.55
Operating Cash Flow to Interest Expense	1.45	6.15	3.07	1.48	2.85	5.91	2.95	0.00	2.31	1.92
Operating Cash Flow Less CapEx to Interest Expense	0.80	4.32	1.67	0.45	1.69	4.54	1.18	0.00	1.39	3.27
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.41	1.41	1.37	1.40	1.41	1.41	0.00	0.00	0.00	1.37
Accounts Receivable Turnover	53.45	54.96	53.58	55.72	51.94	50.33	0.00	0.00	0.00	44.00
Inventory Turnover	1.94	2.10	1.89	1.90	1.86	1.91	0.00	0.00	0.00	1.81
Fixed Asset Turnover	13.42	12.61	13.02	13.30	13.20	12.52	0.00	0.00	0.00	14.23
Accounts Payable Turnover	6.88	6.69	5.87	7.47	7.16	6.85	0.00	0.00	0.00	8.26
Days Sales Outstanding (DSO)	6.83	6.64	6.81	6.55	7.03	7.25	0.00	0.00	0.00	8.30
Days Inventory Outstanding (DIO)	188.63	173.97	192.95	191.88	195.83	190.64	0.00	0.00	0.00	201.35
Days Payable Outstanding (DPO)	53.03	54.60	62.21	48.85	50.96	53.32	0.00	0.00	0.00	44.16
Cash Conversion Cycle (CCC)	142.43	126.01	137.56	149.58	151.90	144.58	0.00	0.00	0.00	165.48
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,867	1,800	1,849	1,913	1,949	1,911	0.00	1,956	1,965	1,950
Invested Capital Turnover	2.40	2.20	2.36	2.03	1.98	2.01	0.00	0.00	0.00	3.82
Increase / (Decrease) in Invested Capital	531	133	484	80	82	111	-1,849	44	16	1,950
Enterprise Value (EV)	2,846	2,854	2,816	3,159	2,790	2,305	0.00	0.00	2,499	2,358
Market Capitalization	1,275	1,348	1,340	1,672	1,328	903	1,431	0.00	1,111	1,065
Book Value per Share	$2.77	$2.74	$3.49	$3.97	$4.53	$4.72	$0.00	$5.28	$5.58	$6.44
Tangible Book Value per Share	($2.69)	($2.64)	($1.96)	($1.48)	($0.91)	($0.74)	$0.00	($0.36)	($0.09)	$0.66
Total Capital	1,968	1,870	1,948	1,974	2,023	2,034	0.00	2,053	2,063	2,055
Total Debt	1,672	1,576	1,575	1,548	1,536	1,525	0.00	1,503	1,485	1,399
Total Long-Term Debt	1,505	1,508	1,509	1,510	1,516	1,521	0.00	1,436	1,436	1,395
Net Debt	1,571	1,506	1,475	1,487	1,461	1,402	0.00	1,405	1,388	1,293
Capital Expenditures (CapEx)	23	32	25	17	22	27	31	0.00	19	-23
Debt-free, Cash-free Net Working Capital (DFCFNWC)	534	463	508	555	580	530	0.00	606	619	597
Debt-free Net Working Capital (DFNWC)	635	533	607	617	654	653	0.00	703	717	702
Net Working Capital (NWC)	468	464	542	578	634	649	0.00	637	668	698
Net Nonoperating Expense (NNE)	26	17	13	12	13	15	13	15	15	13
Net Nonoperating Obligations (NNO)	1,571	1,506	1,475	1,487	1,461	1,402	0.00	1,405	1,388	1,293
Total Depreciation and Amortization (D&A)	26	27	26	26	26	27	29	0.00	29	26
Debt-free, Cash-free Net Working Capital to Revenue	13.89%	12.12%	13.40%	14.60%	15.38%	14.21%	0.00%	0.00%	0.00%	16.02%
Debt-free Net Working Capital to Revenue	16.53%	13.97%	16.01%	16.23%	17.35%	17.51%	0.00%	0.00%	0.00%	18.86%
Net Working Capital to Revenue	12.18%	12.17%	14.29%	15.22%	16.81%	17.40%	0.00%	0.00%	0.00%	18.75%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.44	$0.21	$0.47	$0.38	$0.47	$0.40	$0.00	$0.28	$0.37	$0.60
Adjusted Weighted Average Basic Shares Outstanding	106.94M	108.67M	107.14M	107.45M	107.56M	107.33M	0.00	104.28M	103.19M	102.02M
Adjusted Diluted Earnings per Share	$0.43	$0.21	$0.46	$0.37	$0.46	$0.40	$0.00	$0.27	$0.36	$0.58
Adjusted Weighted Average Diluted Shares Outstanding	108.53M	110.29M	109.46M	109.71M	109.67M	109.34M	0.00	107.08M	105.90M	104.97M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	107.02M	107.04M	107.33M	107.55M	107.77M	106.28M	0.00	103.51M	102.64M	101.95M
Normalized Net Operating Profit after Tax (NOPAT)	73	64	71	59	64	57	51	45	53	74
Normalized NOPAT Margin	7.60%	6.69%	7.43%	6.39%	6.91%	6.14%	5.49%	4.92%	5.66%	7.87%
Pre Tax Income Margin	6.58%	2.26%	7.17%	5.96%	7.68%	6.21%	5.56%	4.30%	5.42%	8.84%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.76	2.25	4.83	4.28	4.83	3.90	3.99	2.90	3.47	5.75
NOPAT to Interest Expense	2.03	2.20	3.54	3.20	3.44	2.90	2.96	2.17	2.56	4.23
EBIT Less CapEx to Interest Expense	2.11	0.41	3.44	3.25	3.67	2.53	2.23	0.00	2.54	7.10
NOPAT Less CapEx to Interest Expense	1.39	0.37	2.15	2.17	2.28	1.54	1.19	0.00	1.64	5.58
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	56.58%	71.00%	33.52%	0.00%	0.00%	8.21%	20.47%	0.00%	0.00%	28.48%

Frequently Asked Questions About Sally Beauty's Financials

When does Sally Beauty's financial year end?

According to the most recent income statement we have on file, Sally Beauty's fiscal year ends in September. Their fiscal year 2024 ended on September 30, 2024.

How has Sally Beauty's net income changed over the last 10 years?

Sally Beauty's net income appears to be on a downward trend, with a most recent value of $153.41 million in 2024, falling from $245.99 million in 2014. The previous period was $184.60 million in 2023. See where experts think Sally Beauty is headed by visiting Sally Beauty's forecast page.

What is Sally Beauty's operating income?

Sally Beauty's total operating income in 2024 was $282.73 million, based on the following breakdown:

Total Gross Profit: $1.89 billion
Total Operating Expenses: $1.61 billion

How has Sally Beauty revenue changed over the last 10 years?

Over the last 10 years, Sally Beauty's total revenue changed from $3.75 billion in 2014 to $3.72 billion in 2024, a change of -1.0%.

How much debt does Sally Beauty have?

Sally Beauty's total liabilities were at $2.16 billion at the end of 2024, a 2.4% decrease from 2023, and a 8.0% decrease since 2014.

How much cash does Sally Beauty have?

In the past 10 years, Sally Beauty's cash and equivalents has ranged from $63.76 million in 2017 to $514.15 million in 2020, and is currently $107.96 million as of their latest financial filing in 2024.

How has Sally Beauty's book value per share changed over the last 10 years?

Over the last 10 years, Sally Beauty's book value per share changed from -2.24 in 2014 to 6.12 in 2024, a change of -373.8%.

Related Companies

This page (NYSE:SBH) was last updated on 5/7/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sally Beauty (SBH) Financials

Frequently Asked Questions About Sally Beauty's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sally Beauty (SBH) Financials

Annual Income Statements for Sally Beauty

Quarterly Income Statements for Sally Beauty

Annual Cash Flow Statements for Sally Beauty

Quarterly Cash Flow Statements for Sally Beauty

Annual Balance Sheets for Sally Beauty

Quarterly Balance Sheets for Sally Beauty

Annual Metrics and Ratios for Sally Beauty

Quarterly Metrics and Ratios for Sally Beauty

Frequently Asked Questions About Sally Beauty's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools